INOTIV INC (NOTV) Stock Fundamental Analysis

NASDAQ:NOTV • US45783Q1004

0.2651 USD
-0.01 (-4.64%)
At close: Feb 24, 2026
0.2704 USD
+0.01 (+2%)
After Hours: 2/24/2026, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, NOTV scores 2 out of 10 in our fundamental rating. NOTV was compared to 58 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of NOTV have multiple concerns. NOTV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NOTV had negative earnings in the past year.
  • In the past year NOTV has reported a negative cash flow from operations.
  • In the past 5 years NOTV reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: NOTV reported negative operating cash flow in multiple years.
NOTV Yearly Net Income VS EBIT VS OCF VS FCFNOTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • NOTV has a Return On Assets (-8.90%) which is in line with its industry peers.
  • NOTV's Return On Equity of -50.45% is on the low side compared to the rest of the industry. NOTV is outperformed by 74.14% of its industry peers.
Industry RankSector Rank
ROA -8.9%
ROE -50.45%
ROIC N/A
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
NOTV Yearly ROA, ROE, ROICNOTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • NOTV's Gross Margin of 23.58% is on the low side compared to the rest of the industry. NOTV is outperformed by 81.03% of its industry peers.
  • NOTV's Gross Margin has declined in the last couple of years.
  • NOTV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
NOTV Yearly Profit, Operating, Gross MarginsNOTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1

2. Health

2.1 Basic Checks

  • NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NOTV has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NOTV has more shares outstanding
  • NOTV has a worse debt/assets ratio than last year.
NOTV Yearly Shares OutstandingNOTV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NOTV Yearly Total Debt VS Total AssetsNOTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -1.18, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
  • NOTV's Altman-Z score of -1.18 is on the low side compared to the rest of the industry. NOTV is outperformed by 72.41% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that NOTV is not too dependend on debt financing.
  • NOTV's Debt to Equity ratio of 0.04 is fine compared to the rest of the industry. NOTV outperforms 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -1.18
ROIC/WACCN/A
WACC7.83%
NOTV Yearly LT Debt VS Equity VS FCFNOTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that NOTV may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.35, NOTV is doing worse than 94.83% of the companies in the same industry.
  • NOTV has a Quick Ratio of 0.35. This is a bad value and indicates that NOTV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOTV has a Quick ratio of 0.27. This is amonst the worse of the industry: NOTV underperforms 94.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.27
NOTV Yearly Current Assets VS Current LiabilitesNOTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

  • NOTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.97%, which is quite impressive.
  • NOTV shows a small growth in Revenue. In the last year, the Revenue has grown by 4.54%.
  • NOTV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.35% yearly.
EPS 1Y (TTM)55.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.63%
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%0.84%

3.2 Future

  • Based on estimates for the next years, NOTV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.30% on average per year.
  • Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.55% on average per year.
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.73%
Revenue Next 2Y4.57%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NOTV Yearly Revenue VS EstimatesNOTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
NOTV Yearly EPS VS EstimatesNOTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

1

4. Valuation

4.1 Price/Earnings Ratio

  • NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOTV Price Earnings VS Forward Price EarningsNOTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • NOTV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NOTV is cheaper than 74.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.52
NOTV Per share dataNOTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.3%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • NOTV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

INOTIV INC

NASDAQ:NOTV (2/24/2026, 8:00:02 PM)

After market: 0.2704 +0.01 (+2%)

0.2651

-0.01 (-4.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-09
Earnings (Next)05-05
Inst Owners23.91%
Inst Owner Change-3.79%
Ins Owners9.63%
Ins Owner Change-3.55%
Market Cap9.12M
Revenue(TTM)513.02M
Net Income(TTM)-68.63M
Analysts82.5
Price Target4.93 (1759.68%)
Short Float %6.47%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.82%
Min EPS beat(2)2.91%
Max EPS beat(2)46.72%
EPS beat(4)3
Avg EPS beat(4)19.11%
Min EPS beat(4)-5.26%
Max EPS beat(4)46.72%
EPS beat(8)5
Avg EPS beat(8)-15.76%
EPS beat(12)7
Avg EPS beat(12)-9.79%
EPS beat(16)11
Avg EPS beat(16)102.67%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-0.13%
Max Revenue beat(2)0.84%
Revenue beat(4)1
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-2.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)8
Avg Revenue beat(16)2.26%
PT rev (1m)0%
PT rev (3m)-12.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)-1.14%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA 18.52
EPS(TTM)-2.03
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS14.91
BVpS3.95
TBVpS-5.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.9%
ROE -50.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.58%
FCFM N/A
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.26
Cap/Depr 29.71%
Cap/Sales 3.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.27
Altman-Z -1.18
F-Score5
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)39.68%
Cap/Depr(5y)78.3%
Cap/Sales(3y)4.2%
Cap/Sales(5y)6.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.63%
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%0.84%
Revenue Next Year3.73%
Revenue Next 2Y4.57%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%
EBIT growth 1Y32.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.64%
OCF growth 3YN/A
OCF growth 5YN/A

INOTIV INC / NOTV FAQ

Can you provide the ChartMill fundamental rating for INOTIV INC?

ChartMill assigns a fundamental rating of 2 / 10 to NOTV.


What is the valuation status for NOTV stock?

ChartMill assigns a valuation rating of 1 / 10 to INOTIV INC (NOTV). This can be considered as Overvalued.


What is the profitability of NOTV stock?

INOTIV INC (NOTV) has a profitability rating of 1 / 10.


What is the expected EPS growth for INOTIV INC (NOTV) stock?

The Earnings per Share (EPS) of INOTIV INC (NOTV) is expected to grow by 8.11% in the next year.